UK Govt Under Fire From Pharma Industry Over Statutory Pricing Scheme Changes

 
• By Eliza Slawther

The UK’s pharmaceutical industry association, the ABPI, claims that “fundamental failures” in the government’s consultation and impact assessment for proposed changes to the branded medicines statutory pricing scheme could be grounds for legal challenge.

Miscalculation
ABPI: The DHSC miscalculated the costs and benefits of its proposed statutory scheme changes • Source: Shutterstock

More from Europe

More from Geography